Exicure (XCUR) Research & Development (2016 - 2026)
Exicure's Research & Development came in at $174,000 for Q2 2026, down 81.4% from $935,000 a year earlier and down 44.2% from the prior quarter.
Powered by 
Analysis
Exicure (XCUR) Research & Development (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Exicure reported Research & Development of $2.03 million, up 16.4% year-over-year; for FY2025, it came in at $3.29 million.
- Research & Development carries a five-year compound annual growth rate of -36.6% (FY2020 to FY2025).
- Going back by year, Research & Development was $1.42 million in FY2023 (-92.8%), $19.77 million in FY2022 (-59.6%) and $48.98 million in FY2021 (+52.6%).
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q3 2016.
- The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 80.1%), and the weakest in Q4 2022 (a decline of 90.6%).
- Business Quant data shows XCUR's Research & Development at $312,000 (Q1 2026), $655,000 (Q4 2025) and $888,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,176.80 Bn | 1,145.39 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 639.81 Bn | 558.34 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.28 Bn | 476.39 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 376.70 Bn | 331.08 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 268.37 Bn | 242.05 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 242.34 Bn | 197.74 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.58 Bn | 167.78 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.88 Bn | 119.53 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Exicure | 7.58 Mn | -4.92 Mn | - | 174,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174,000.00 |
| Mar 31, 2026 | 312,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 888,000.00 |
| Jun 30, 2025 | 935,000.00 |
| Mar 31, 2025 | 808,000.00 |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 4.81 Mn |
| Jun 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 7.14 Mn |
| Dec 31, 2021 | 11.42 Mn |
| Sep 30, 2021 | 16.46 Mn |
| Jun 30, 2021 | 10.84 Mn |
| Mar 31, 2021 | 10.26 Mn |
| Dec 31, 2020 | 9.87 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Jun 30, 2020 | 7.01 Mn |
| Mar 31, 2020 | 6.08 Mn |
| Dec 31, 2019 | 8.27 Mn |
API Access
Exicure Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=XCUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "XCUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=XCUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();